U.S. Judge Blocks Parts Of Robert F. Kennedy Jr.’s Vaccine Overhaul, Halts Advisory Panel Shake-Up

A federal judge in Massachusetts has blocked significant portions of a sweeping overhaul of U.S. vaccine policy led by Health and Human Services Secretary Robert F. Kennedy Jr., dealing a legal setback to the administration’s efforts to reshape national immunization guidelines.

U.S. District Judge Brian Murphy ruled that parts of the policy changes were likely unlawful and risked undermining long-standing public health practices that have guided vaccination efforts for decades.

COURT SIDES WITH MEDICAL GROUPS

The ruling followed a legal challenge brought by the American Academy of Pediatrics and several other medical organizations, which argued that the administration acted improperly in restructuring vaccine recommendations and advisory bodies.

Judge Murphy wrote that U.S. public health policy has historically relied on vaccination to control and eliminate infectious diseases. He said the recent changes appeared to disregard those established methods, raising concerns about the integrity and consistency of federal health decisions.

Medical groups had warned that weakening vaccine guidance could lead to increased illness and deaths from diseases that are otherwise preventable.

ADVISORY PANEL SHAKE-UP HALTED

A central focus of the ruling was Kennedy’s overhaul of the Advisory Committee on Immunization Practices (ACIP), a key expert panel that guides vaccine recommendations for the Centers for Disease Control and Prevention.

Kennedy dismissed all 17 original members of the committee and replaced them with new appointees. Critics argued that several of the replacements lacked relevant qualifications or had ties to anti-vaccine advocacy.

The court blocked 13 of those new appointees from continuing in their roles, effectively suspending the reconstituted panel ahead of a scheduled March 18–19 meeting.

The Department of Health and Human Services confirmed that the meeting has been postponed.

PREVIOUS VACCINE DECISIONS INVALIDATED

Judge Murphy also ruled that actions taken by the newly formed panel were not legally valid.

That includes votes to scale back recommendations for hepatitis B vaccinations in newborns and to reduce broad guidance supporting COVID-19 vaccinations.

The decision casts uncertainty over recent federal vaccine guidance and may require agencies to revisit or restore earlier recommendations.

CONTROVERSIAL POLICY SHIFTS

Kennedy has introduced several major changes to vaccine policy since taking office.

These include removing certain vaccines from the routine childhood schedule, altering recommendations for COVID-19 vaccines in children and pregnant women, and splitting the combined measles, mumps and rubella (MMR) vaccine into separate doses.

Supporters of the changes say they promote individual choice and align U.S. policy more closely with some other developed nations.

Critics argue the moves weaken evidence-based standards and risk lowering vaccination rates.

PUBLIC HEALTH CONCERNS INTENSIFY

Major medical institutions and public health experts have strongly criticized the policy direction.

Some have warned that reduced vaccine uptake could lead to outbreaks of diseases that had been largely controlled in the United States.

In response to earlier federal changes, pediatric groups issued their own independent immunization guidance, signaling a breakdown in trust between government agencies and parts of the medical community.

Kennedy has defended his approach, saying vaccines remain available and that individuals should have greater autonomy in making health decisions.

ADMINISTRATION PUSHES BACK

The Department of Health and Human Services criticized the ruling and indicated it expects the decision to be overturned on appeal.

Officials argue that the administration has the authority to reshape advisory panels and update health recommendations.

The case adds to a series of legal battles involving Judge Murphy, who has previously blocked or limited several administration policies across areas including immigration and federal programs.

LEGAL AND POLICY UNCERTAINTY AHEAD

The ruling leaves U.S. vaccine policy in a period of uncertainty.

Key advisory structures are paused, recent recommendations are in question, and a broader legal fight appears likely.

For now, the court’s decision restores a measure of continuity to longstanding public health practices, while setting up a high-stakes confrontation over how far the government can go in redefining vaccine policy in the United States.